Clinical Trial Update: The Study on the Esketamine in the Treatment of Postherpetic Neuralgia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on esketamine for postherpetic neuralgia is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• Esketamine (esketamine)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Postherpetic Neuralgia, Esketamine | Phase 4 | Status: UNKNOWN